Project Chill: Tailored Youth Drug Intervention In Primary Care

Status Completed

Clinical Trial Summary

This study examines the impact of tailored computer-delivered and therapist-delivered brief motivations prevention/interventions both for adolescents who have not initiated marijuana use (prevention), and those who use marijuana (intervention). Key moderators of prevention/intervention effectiveness will be examined, including behavioral intentions, self-efficacy, stage of change, school involvement, susceptibility to peer pressure, and potential health consequences such as STD/HIV risk behaviors. This project will provide the critical first step toward the development and implementation of marijuana use prevention/intervention programs that have the potential to be delivered to a large segment of youth who seek care in our nation's primary care settings.

Clinical Trial Description

The primary care setting represents an underutilized venue for prevention interventions addressing drug use/abuse among youth. The purpose of the study is to: (1) develop and refine promising, empirically-derived, BMI prevention/intervention modules delivered by a clinician or a computer to target marijuana use, and (2) test the effectiveness of BMI in preventing initiation/escalation of marijuana use among youth in community health clinics. This randomized controlled trial screened adolescents in primary care clinics in Flint, MI. A random sample of those who screened negative for past year marijuana use were selected to participate in the study and all subjects who screened positive for past year use were enrolled in the study. These subjects were stratified by gender, age, and past year marijuana use and randomized to one of three conditions: 1) computer-delivered brief motivational approach (BMI-C); 2) therapist-delivered brief motivational approach (BMI-T); or 3) a NIDA drug education booklet. Primary outcomes are evaluated at 3-, 6- and 12-months and include marijuana, alcohol, tobacco and other drug use. Key moderators of effectiveness will be examined, including behavioral intentions, self-efficacy, stage of change, school involvement, susceptibility to peer pressure, and potential health consequences (e.g., STD/HIV risk behaviors). This project will provide the critical first step toward the implementation of tailored marijuana prevention and intervention in primary care clinics. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Marijuana Use

Clinical Trial Details

NCT number	NCT01329315
Study type	Interventional
Source	University of Michigan
Contact
Status	Completed
Phase	N/A
Start date	September 2005
Completion date	November 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02191605` - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy	N/A
Completed	`NCT02837315` - Improving Brief Marijuana Interventions With a Behavioral Economic Supplement	N/A
Completed	`NCT02387489` - A Clinical Trial of SBIRT Services in School-based Health Centers	N/A
Recruiting	`NCT05309226` - Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health
Active, not recruiting	`NCT04617938` - TACUNA (Traditions and Connections for Urban Native Americans)	N/A
Completed	`NCT02530645` - Development and Testing of a Smartphone Application to Reduce Substance Use and Sexual Risk Among Homeless Young Adults	N/A
Completed	`NCT02290938` - Motivational Interviewing and Culture for Urban Native American Youth (MICUNAY)	N/A
Completed	`NCT01473719` - Emerging Adults Who Use Alcohol and Marijuana	Phase 3
Not yet recruiting	`NCT06077292` - Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults	N/A
Completed	`NCT05362357` - iSTART: A Campus & Community Initiative for Services in Tec-health	N/A
Completed	`NCT00403117` - Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana	Phase 2
Recruiting	`NCT05485012` - Reinforcing Effects of Marijuana and Opioids	Phase 1
Completed	`NCT04965012` - Testing the Efficacy of an Online Treatment Program for Heavy Cannabis Use	N/A
Recruiting	`NCT04827992` - Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain	N/A
Completed	`NCT04968275` - A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis	N/A
Completed	`NCT04783519` - Research Evaluating Sleep & Trends for Universal Prevention	N/A
Recruiting	`NCT05324813` - Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use	N/A
Recruiting	`NCT04737772` - Project CheckUP: A Brief Behavioral Intervention for Quitline Callers Who Use Marijuana (MJ) and Tobacco	N/A
Not yet recruiting	`NCT04855526` - THC + CBD and Memory Study	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.